Investors

Press Releases


All Releases
View Summary Trius Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin
May 13, 2013
PDF 10.0 KB Add to Briefcase
View Summary Trius Therapeutics Reports First Quarter 2013 Financial Results
May 7, 2013
PDF 16.4 KB Add to Briefcase
View Summary Trius Therapeutics Presents Clinical Data on Experimental Antibiotic Tedizolid at ECCMID Meeting
Apr 29, 2013
PDF 13.9 KB Add to Briefcase
View Summary Trius Therapeutics to Present Experimental Antibiotic Study Results at ECCMID Meeting
Apr 23, 2013
PDF 14.4 KB Add to Briefcase
View Summary Trius Appoints Seth Fischer to Its Board of Directors
Apr 3, 2013
PDF 10.5 KB Add to Briefcase
View Summary Trius to Present at Future Leaders Conference
Apr 2, 2013
PDF 7.2 KB Add to Briefcase
View Summary Trius Announces Positive Results From ESTABLISH 2 Study of Tedizolid in Severe Skin Infections
Mar 25, 2013
PDF 57.9 KB Add to Briefcase
View Summary Trius Therapeutics Reports 2012 Fourth Quarter and Full Year 2012 Financial Results
Mar 12, 2013
PDF 17.7 KB Add to Briefcase
View Summary Trius Announces Publication of Tedizolid ESTABLISH 1 Trial in JAMA
Feb 12, 2013
PDF 12.1 KB Add to Briefcase
View Summary Trius Therapeutics, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares for Common Stock Offering
Jan 23, 2013
PDF 10.7 KB Add to Briefcase
View Summary Trius Therapeutics, Inc. Prices Public Offering of Common Stock
Jan 18, 2013
PDF 10.3 KB Add to Briefcase
View Summary Trius Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Jan 17, 2013
PDF 10.3 KB Add to Briefcase
View Summary Tedizolid Receives Qualified Infectious Disease Product (QIDP) Designation From FDA
Jan 7, 2013
PDF 10.7 KB Add to Briefcase
View Summary Trius Therapeutics Completes Enrollment in Second Phase 3 Trial of Tedizolid for Skin and Skin Structure Infections
Dec 10, 2012
PDF 10.0 KB Add to Briefcase
View Summary Trius Therapeutics Ranked Number 42 Fastest Growing Company in North America on Deloitte's 2012 Technology Fast 500(TM)
Nov 14, 2012
PDF 10.2 KB Add to Briefcase
View Summary Trius to Present at November Investor Conferences
Nov 12, 2012
PDF 7.3 KB Add to Briefcase
View Summary Trius Therapeutics to Host Analyst and Investor Update Call
Nov 8, 2012
PDF 8.1 KB Add to Briefcase
View Summary Trius Therapeutics Reports 2012 Third Quarter Financial Results
Nov 5, 2012
PDF 17.8 KB Add to Briefcase
View Summary Tedizolid Safety Data Presented at IDWeek
Oct 19, 2012
PDF 12.2 KB Add to Briefcase
View Summary Trius Therapeutics to Present Data From Tedizolid Clinical Studies at IDWeek Conference
Oct 16, 2012
PDF 12.2 KB Add to Briefcase
Showing 1-20 of 101 Page: 1 2 3 ... 6  Next 20
=add release to Briefcase